KR890006224A - 소마토트로핀 제형 - Google Patents
소마토트로핀 제형 Download PDFInfo
- Publication number
- KR890006224A KR890006224A KR1019880013950A KR880013950A KR890006224A KR 890006224 A KR890006224 A KR 890006224A KR 1019880013950 A KR1019880013950 A KR 1019880013950A KR 880013950 A KR880013950 A KR 880013950A KR 890006224 A KR890006224 A KR 890006224A
- Authority
- KR
- South Korea
- Prior art keywords
- formulation
- formulation according
- fatty acid
- polypeptide material
- oil
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title claims 19
- 239000000203 mixture Substances 0.000 title claims 19
- 108010051696 Growth Hormone Proteins 0.000 title claims 2
- 102000018997 Growth Hormone Human genes 0.000 title claims 2
- 238000010521 absorption reaction Methods 0.000 claims 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- -1 fatty acid salts Chemical class 0.000 claims 4
- 239000000463 material Substances 0.000 claims 4
- 239000003921 oil Substances 0.000 claims 4
- 229920001184 polypeptide Polymers 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 241000283690 Bos taurus Species 0.000 claims 2
- 230000002745 absorbent Effects 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 108010006025 bovine growth hormone Proteins 0.000 claims 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical group [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 1
- 235000013539 calcium stearate Nutrition 0.000 claims 1
- 239000008116 calcium stearate Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도 및 제2도는 4마리의 양의 평균 혈장 BST 수준을 주사 3일전부터 24일간에 걸쳐 나타낸 것이다.
제3도는 시험 송아지의 요소 질소 수준을 28일간 비처리 대조 동물의 그것과 비교한 것이다.
Claims (17)
- 천연 또는 합성 오일로 이루어지는 흡수가능한 생물 혼화성 기제, 및 지방산 염 및 흡수 조절제로부터 선택되는적어도 하나의 성분을 함유하는 담체에 분산된 유효 농도의 폴리펩티드 물질을 함유하는, 폴리펩티드 물질의 주사 가능한 서방성 제형.
- 제1항에 있어서, 폴리펩티드 물질이 소의 소마토트로핀이 제형.
- 제1항 또는 제2항에 잇어서, 지방산염 및 흡수 조절제 둘다를 함유하는 제형.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 2,000 내지 250,000CPS 범위의 점도를 갖는 제형.
- 제4항에 있어서, 점도가 10,000 내지 200,000 CPS범위인 제형.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 지방산 염이 칼슘 스테아레이트인 제형.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 흡수 조절제가 택스트란인 제형.
- 제1항 내지 제7항 중 어느 한 항에 있어서, 오일이 호마유인 제형.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 지방산 염 대 흡수 조절제의 비가 1:95 내지 95:1 범위인 제형.
- 제8항에 있어서, 비가 1:9 내지 9:1 범위인 제형.
- 제10항에 있어서, 비가 1:1 내지 3:1 범위인 제형.
- 제1항 내지 제1항 중 어느 한 항에 있어서, 오일을 30중량%이상 함유하는 제형.
- 제1항 내지 제12항 중 어느 한 항에 있어서, 폴리펩티드 물질이 미세과립 형태로 존재하는 제형.
- 제13항에 있어서, 미세과립의 크기가 50 내지 500미크론 제형.
- 제1항 내지 제14항 중 어느 한 항에 있어서, 소외 소마토느로핀이 제형의 5 내지 45 중량%를 차지하는 제형.
- 제15항에 있어서, 중량범위가 15 내지 30%인 제형.
- 제1항 내지 제16항 중 어느 한 항에 청구된 유효량의 제형을 젖소에게 투여함을 특징으로 하여, 젖소의 우유 생산을 증가시키는 방법.※ 참고사항 : 최초 출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8725427 | 1987-10-30 | ||
| GB878725427A GB8725427D0 (en) | 1987-10-30 | 1987-10-30 | Somatotropin formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR890006224A true KR890006224A (ko) | 1989-06-12 |
Family
ID=10626158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880013950A KR890006224A (ko) | 1987-10-30 | 1988-10-26 | 소마토트로핀 제형 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0314421A1 (ko) |
| JP (1) | JPH01149732A (ko) |
| KR (1) | KR890006224A (ko) |
| CN (1) | CN1032743A (ko) |
| AU (1) | AU618760B2 (ko) |
| DK (1) | DK597388A (ko) |
| GB (1) | GB8725427D0 (ko) |
| HU (1) | HUT48467A (ko) |
| IL (1) | IL88148A0 (ko) |
| MX (1) | MX26698A (ko) |
| NZ (1) | NZ226723A (ko) |
| PH (1) | PH25793A (ko) |
| PT (1) | PT88859A (ko) |
| ZA (1) | ZA888067B (ko) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0422290A1 (en) * | 1989-10-09 | 1991-04-17 | Eli Lilly And Company | Novel drug delivery system |
| NZ237084A (en) * | 1990-02-12 | 1993-10-26 | Lucky Ltd | Composition for the prolonged release of somatotropin comprising the somatotropin, a tocopherol component, and an assistant delaying agent |
| YU87892A (sh) * | 1991-10-01 | 1995-12-04 | Eli Lilly And Company Lilly Corporate Center | Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu |
| KR19990071255A (ko) | 1998-02-28 | 1999-09-15 | 성재갑 | 소마토트로핀과 비타민의 합제 조성물 |
| KR20080011353A (ko) * | 2000-02-24 | 2008-02-01 | 몬산토 테크놀로지 엘엘씨 | 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들 |
| US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
| WO2003034988A2 (en) * | 2001-10-19 | 2003-05-01 | Idexx Laboratories, Inc. | Injectable compositions for the controlled delivery of pharmacologically active compound |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1155036A (en) * | 1966-07-08 | 1969-06-11 | Ethan Allan Brown | Injectionable Substance |
| EP0140255B1 (en) * | 1983-10-14 | 1991-05-15 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release injections |
| KR890002631B1 (ko) * | 1984-10-04 | 1989-07-21 | 몬산토 캄파니 | 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물 |
| EP0193917A3 (en) * | 1985-03-06 | 1987-09-23 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
| IL79552A0 (en) * | 1985-07-30 | 1986-10-31 | Int Minerals & Chem Corp | Stabilization of growth promoting hormones |
| US4775659A (en) * | 1985-08-19 | 1988-10-04 | Eli Lilly And Company | Injectable semi-solid formulations |
| IL79765A (en) * | 1985-08-23 | 1992-02-16 | Lilly Co Eli | Injectable sustained release formulations of bovine somatotropin |
| ES2039219T3 (es) * | 1986-08-11 | 1993-09-16 | American Cyanamid Company | Composiciones para administracion parenteral y su uso. |
-
1987
- 1987-10-30 GB GB878725427A patent/GB8725427D0/en active Pending
-
1988
- 1988-10-25 IL IL88148A patent/IL88148A0/xx unknown
- 1988-10-25 AU AU24313/88A patent/AU618760B2/en not_active Ceased
- 1988-10-25 MX MX2669888A patent/MX26698A/es unknown
- 1988-10-25 EP EP88309997A patent/EP0314421A1/en not_active Withdrawn
- 1988-10-26 NZ NZ226723A patent/NZ226723A/en unknown
- 1988-10-26 KR KR1019880013950A patent/KR890006224A/ko not_active Application Discontinuation
- 1988-10-26 PT PT88859A patent/PT88859A/pt not_active Application Discontinuation
- 1988-10-27 DK DK597388A patent/DK597388A/da not_active Application Discontinuation
- 1988-10-27 CN CN88107461A patent/CN1032743A/zh active Pending
- 1988-10-27 ZA ZA888067A patent/ZA888067B/xx unknown
- 1988-10-27 PH PH37734A patent/PH25793A/en unknown
- 1988-10-28 JP JP63272854A patent/JPH01149732A/ja active Pending
- 1988-10-28 HU HU885635A patent/HUT48467A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT88859A (pt) | 1989-07-31 |
| PH25793A (en) | 1991-11-05 |
| AU618760B2 (en) | 1992-01-09 |
| MX26698A (es) | 1993-10-01 |
| ZA888067B (en) | 1990-06-27 |
| DK597388A (da) | 1989-05-01 |
| DK597388D0 (da) | 1988-10-27 |
| IL88148A0 (en) | 1989-06-30 |
| HUT48467A (en) | 1989-06-28 |
| EP0314421A1 (en) | 1989-05-03 |
| CN1032743A (zh) | 1989-05-10 |
| AU2431388A (en) | 1989-05-04 |
| GB8725427D0 (en) | 1987-12-02 |
| JPH01149732A (ja) | 1989-06-12 |
| NZ226723A (en) | 1991-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT92622A (pt) | Processo para a preparacao de uma composicao cosmetica ou farmaceutica contendo microsferas de polimeros ou de corpos gordos carregadas com pelo menos um produto activo | |
| MX173196B (es) | Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo | |
| KR890006224A (ko) | 소마토트로핀 제형 | |
| SE8304144L (sv) | Forfarande for forlengning av uppehallstiden for emulsionspartiklar i blodomloppet | |
| KR910007542A (ko) | 폴리펩타이드의 서방형 조성물 | |
| ATE55056T1 (de) | Einfach absorbierbare fettsaeureemulsionen. | |
| DE3879286D1 (de) | Fluessige dispersion zur oralen verabreichung. | |
| ATE185046T1 (de) | Eigenschaften von gesichtpheromonen von katzen | |
| ATE35500T1 (de) | Verfahren zur einkapselung von fett. | |
| KR830003536A (ko) | 불용성유황의 유(油)처리방법 | |
| KR910005768A (ko) | 동물사료용의 안정한 항생물질 조성물 | |
| KR900005944A (ko) | 골 재생물질 및 인공 골 고정제 | |
| KR880002184B1 (ko) | 사료 첨가 조성물 | |
| KR830005863A (ko) | 인체 융모성선자격 호르몬의 제조방법 | |
| KR910011151A (ko) | 소, 돼지용 항병성사료 및 사료용 첨가물 | |
| EP0043202A3 (en) | Additive composition for animal feedingstuff | |
| KR870000022A (ko) | 분말없는 올라퀸독스-함유 사료 혼합물의 제조방법 | |
| TR25174A (tr) | Yag icinde su dispersiyonu ve böyle bir disper- siyon hazirlamaya mahsusyöntem | |
| ES2090969T3 (es) | Composicion inyectable que contiene microcapsulas de colageno. | |
| NO871782L (no) | Elastomert pife-materiale, anvendelse av dette, samt fremstilling av det. | |
| KR920016021A (ko) | 동물의 발육 촉진 또는 개선 사료 및 방법 | |
| KR890701029A (ko) | 식품의 제조법 | |
| ATE55867T1 (de) | Produkt zur fuetterung von wiederkaeuern und seine herstellung. | |
| KR890015678A (ko) | 소르비톨 및 인산염 함유의 고체 조성물 | |
| PT90802A (pt) | Processo para a preparacao de derivados de propanolamina e de composicoes farmaceuticas que os contem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |